Back
Kaleido Biosciences, Inc. 10K Form
Sell
14
KLDO
Kaleido Biosciences, Inc.
Last Price:
$0.0000
Seasonality Move:
-21.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KLDO News And Ratings
See the #1 stock for the next 7 days that we like better than KLDO
KLDO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $-1.3M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Kaleido Biosciences, Inc. Earnings Forecast
Key Kaleido Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for KLDO is -113.59%.
-
The Selling, General & Administrative Expenses for KLDO have been equal to 1,899.28% of Gross Profit Margin.
-
The Research & Development expenses have been 6,141.58% of Revenue.
-
The Net Earning history of KLDO is -8,178.26% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Kaleido Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | KLDO |
| CUSIP: | 483347 |
| Website: | kaleido.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KLDO Technical Analysis vs Fundamental Analysis
Sell
14
Kaleido Biosciences, Inc. (KLDO)
is a Sell
Is Kaleido Biosciences, Inc. a Buy or a Sell?
-
Kaleido Biosciences, Inc. stock is rated a SellThe current Kaleido Biosciences, Inc. [KLDO] share price is $0.0001. The Score for KLDO is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.